March 13, 2018 / 11:11 AM / 3 months ago

BRIEF-Aralez Pharmaceuticals Posts Q4 Loss Per Share $0.68‍‍​

* ARALEZ ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

* ‍TOTAL REVENUE FOR Q4 OF 2017 WERE $28.0 MILLION, AN INCREASE OF $8.0 MILLION, OR 40%, COMPARED TO $20.0 MILLION FOR SAME PERIOD OF 2016​

* QTRLY LOSS PER SHARE $0.68‍​

* ‍2018 NET REVENUES TO BE IN A RANGE OF $140 MILLION TO $160 MILLION​

* SEES ‍2018 ADJUSTED EBITDA TO BE IN A RANGE OF $35 MILLION TO $55 MILLION​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below